세계의 약제 용출 스텐트 시장 : 약제 코팅, 용도별 예측(2025-2030년)

The Drug Eluting Stent Market was valued at USD 7.27 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 10.84%, to USD 14.94 billion by 2030.

Drug-eluting stents (DES) are specialized coronary stents used in interventional cardiology to prevent the recurrence of arteriosclerotic blockages in coronary arteries. These stents are coated with medication that is gradually released to inhibit cell proliferation, thus maintaining vessel patency effectively. The necessity for DES arises from the need to improve outcomes of percutaneous coronary interventions by minimizing restenosis, a common complication associated with bare-metal stents. Widely utilized in cardiology, their applications extend to treating coronary artery disease, and hospitals and specialized cardiac centers represent the primary end-users. Key growth factors for the DES market include the rising prevalence of cardiovascular diseases globally, an aging population, and technological advancements that enhance stent efficacy and biocompatibility. Furthermore, ongoing research into novel drug formulations and bioresorbable stents offers promising growth opportunities. Companies could explore strategic partnerships and invest in research to develop next-generation stents to remain competitive. However, market growth faces challenges such as stringent regulatory requirements, high costs of DES, and reimbursement issues that could hinder adoption, especially in developing economies. Potential limitations also include complications like late stent thrombosis, necessitating extended dual antiplatelet therapy. To capture emerging opportunities, businesses should focus on innovation in drug coatings, promoting biodegradable options, and expanding in underserved markets with growing healthcare infrastructure. The market remains highly competitive, underscored by aggressive R&D in product development and frequent mergers and acquisitions aimed at expanding market share. Success relies on the ability to balance innovation with cost-effectiveness, navigating regulatory landscapes, and effectively addressing patient safety concerns. By strategically targeting emerging markets and investing in cutting-edge technologies, companies can leverage significant growth potential within the dynamic landscape of drug-eluting stents.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Stent Market

The Drug Eluting Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing geriatric population along with growing high risk of developing arterial diseases
  • Rising prevalence rate of atherosclerosis
  • Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
• Market Restraints
  • Risks associated with drug eluting stent
• Market Opportunities
  • Introduction of bio resorbable stents support minimally invasive surgeries
  • Improving healthcare infrastructure in emerging economies
• Market Challenges
  • Issues related to product recall

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Stent Market

A detailed market share analysis in the Drug Eluting Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Eluting Stent Market

A strategic analysis of the Drug Eluting Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvimedica, Arkray, Inc., B. Braun, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, Cook Medical LLC, HEXACATH, KYOTO MEDICAL PLANNING Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, REVA Medical LLC, Shandong JW Medical Systems LTD., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Coating, market is studied across Polymer Free Coatings and Polymer-Based Coatings. The Polymer Free Coatings is further studied across Micro Porous Surface, Micro Structured Surface, Nanoporous Surface, and Slotted Tubular Surface. The Polymer-Based Coatings is further studied across Biodegradable Polymers and Non-Biodegradable Polymers.
• Based on Application, market is studied across Coronary Artery Disease and Peripheral Artery Disease.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population along with growing high risk of developing arterial diseases
    • 5.1.1.2. Rising prevalence rate of atherosclerosis
    • 5.1.1.3. Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
  • 5.1.2. Restraints
    • 5.1.2.1. Risks associated with drug eluting stent
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of bio resorbable stents support minimally invasive surgeries
    • 5.1.3.2. Improving healthcare infrastructure in emerging economies
  • 5.1.4. Challenges
    • 5.1.4.1. Issues related to product recall
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Eluting Stent Market, by Drug Coating

• 6.1. Introduction
• 6.2. Polymer Free Coatings
  • 6.2.1. Micro Porous Surface
  • 6.2.2. Micro Structured Surface
  • 6.2.3. Nanoporous Surface
  • 6.2.4. Slotted Tubular Surface
• 6.3. Polymer-Based Coatings
  • 6.3.1. Biodegradable Polymers
  • 6.3.2. Non-Biodegradable Polymers

7. Drug Eluting Stent Market, by Application

• 7.1. Introduction
• 7.2. Coronary Artery Disease
• 7.3. Peripheral Artery Disease

8. Americas Drug Eluting Stent Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Drug Eluting Stent Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Drug Eluting Stent Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alvimedica
• 3. Arkray, Inc.
• 4. B. Braun
• 5. Biosensors International Group, Ltd.
• 6. Biotronik
• 7. Boston Scientific Corporation
• 8. Cook Medical LLC
• 9. HEXACATH
• 10. KYOTO MEDICAL PLANNING Co., Ltd.
• 11. Lepu Medical Technology (Beijing) Co., Ltd.
• 12. Medtronic PLC
• 13. Meril Life Sciences Pvt. Ltd.
• 14. MicroPort Scientific Corporation
• 15. REVA Medical LLC
• 16. Shandong JW Medical Systems LTD.
• 17. Terumo Corporation